I
Agenda
I
I
I
I
I
I

Scientific Agenda

Friday, May 5, 2006
Sheraton Centre Toronto Hotel, Toronto, Ontario
Symposium organized by the Canadian Heart Research Centre

Agenda

 

A Morning with Ventricular Tachyarrhythmias

Moderator:
Brent Mitchell, MD

08:00

New clinical guidelines for prophylactic ICD therapy

Christopher Simpson, MD

08:30

ACLS guidelines: What is new? What is the data?

Paul Dorian, MD

09:00

Cardiac resynchronization therapy: Changing paradigms of heart
failure management

Malcolm Arnold, MD

09:30

Investigation and management of the patient with recurrent syncope: New guidelines

Andrew Krahn, MD

10:15

Panel discussion

 

10:45

Break

 

11:00

WORKSHOP

 

  Case discussion: Atrial fibrillation George Wyse, MD
  Case discussion: ECG interpretation Luigi Casella, MD
  Case discussion: CRT Malcolm Arnold, MD
  Case discussion: Restriction of driving privileges       Brent Mitchell, MD

12:00

Lunch

 

 

An afternoon with Atrial Fibrillation

 Moderator:
Paul Dorian, MD

13:00

Clinical trials of antithrombotic therapy for AF: Recent clinical trials and new directions

Stuart Connolly, MD

13:30

Management of AF: Rate control or rhythm control?

George Wyse, MD

14:00

Optimizing rate and rhythm control

Paul Dorian, MD

14:30

AF and hypertension: Non-antiarrhythmic drug therapy for AF

Jeff Healey, MD

15:00

Panel discussion

 

15:30

Break

 

15:50

Debate: For patients with AF in the absence of evidence structural heart disease, therapy with antiarrhythmic drugs should precede consideration of curative ablation therapy

Brent Mitchell, MD & Allan Skanes, MD

16:50

Close

 

  

Participants will have increased ability to:

  • Initiate appropriate first line therapy for patients in their practice with cardiac arrhythmias
  • Recognize patients with cardiac arrhythmias which constitute a threat to life and warrant immediate assessment and therapy
  • Recognize patients without cardiac arrhythmias who are at high risk of development arrhythmias that are a threat to life and, therefore, require prophylactic therapy
  • Provide medical therapies to patients with cardiac arrhythmias
  • Understand the use of ancillary medical therapies in patients with cardiac arrhythmias treated with an implantable device
  • Provide an initial trouble-shooting service to patients with cardiac arrhythmias treated with an implantable device
  • Use multiple anti-arrhythmic therapies in complicated patients                
This education event has been approved for 7 MAINPRO-M1 credits, and as an
Accredited Group Learning Activity under Section 1 of the Framework of CPD
options for the Maintenance of Certification Program of the Royal College of
Physicians and Surgeons of Canada (7 hours).